Particle shows promise for treating the most deadly type of breast cancer

Metastatic breast cancer cells (yellow) interacting with macrophages (magenta) (Image by Oihana Iriondo/Yu Lab)

USC Stem Cell researchers from the laboratory of Min Yu have positive news for patients with triple-negative breast cancer (TNBC), the most deadly type of breast cancer. By inhibiting a protein called TAK1, postdoc Oihana Iriondo and her colleagues reduced lung metastases in mice with TNBC, as described in a new study in Nature Communications.

To read more, visit stemcell.keck.usc.edu/particle-shows-promise.